Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Sue

Middleton

President (GSK Vaccines)

Florence

Baron-Papillon

Vice - President (Sanofi Pasteur)

Andreas

Potthoff

(Abbott)

Hans

Sijbesma

(AstraZeneca)

Nicoletta

Luppi

(MSD)

Sharon

McHale

(Seqirus)

Jurgen

Kwik

(Janssen/JnJ)

Cornelia

Oostvogels

(Curevac)

Logan

Rae

(Takeda)

Sinan

Atlig

Treasurer (Pfizer)

Executive office

Sibilia

Quilici

Executive Director

Anna

Swierczyna

Government Affairs and Policy Manager

Anna

Czwarno

Director, Regulatory and R&D

Anne

Meynaerts

Administrative Assistant

Working Group Chairs